Staging.mdxhealth.com
MDxHealth Announces Proposed Transition to a Sole Listing of …
WebNEWS RELEASE – REGULATED INFORMATION INSIDE INFORMATION OCTOBER 2, 2023, 4:00pm ET / 22:00 CET MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting. IRVINE, CA, and HERSTAL, BELGIUM – October 2, 2023 – MDxHealth SA …
Actived: 1 days ago
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial …
WebFourth Quarter 2023 Financial Results. Revenue increased 50% to $19.4 million compared to $12.9 million for the prior year. Revenue was comprised of $8.8 million from GPS, $5.9 million from Confirm mdx, $3.2 million from Resolve mdx, and $1.3 million from Select mdx. Gross margins were 65.3% compared to 56.0% for the prior year, an …
MDxHealth Announces the Approval by its Shareholders of the …
WebWhile at Assurex Health (Myriad Genetics) revenue grew from $700k to a run rate of $100 Million during his 5 year span with the organization. CLOSE Miriam Reyes Executive Vice President of Operations. Miriam Reyes has 25 years of experience in life science and laboratory operations, and R&D. She has served as Operations Leader at …
Mdxhealth Acquires Oncotype DX® GPS Prostate Cancer Business …
WebNEWS RELEASE – INSIDE AND REGULATED INFORMATION August 2, 2022, 4:00PM EDT / 22:00 CET Mdxhealth Acquires Oncotype DX® GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results Solidifies leadership in the precision diagnostics urology market Provides the most comprehensive …
MDxHealth Reports Financial Year 2021 Results and Provides …
WebNEWS RELEASE – REGULATED INFORMATION 2 MARCH 2022, 4:00 PM EST / 22:00 CET. MDxHealth Reports Financial Year 2021 Results and Provides Outlook and Guidance for 2022. Conference call with Q&A today at 4:30 PM EST / 22:30 CET. IRVINE, CA, and HERSTAL, BELGIUM – March 2, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH), a …
MDxHealth Reports Fourth Quarter and Fiscal Year 2015 Results
WebIRVINE, CA, and HERSTAL, BELGIUM – 7:00 AM, February 18, 2016 – MDxHealth SA (Euronext: MDXH.BR) today announced its financial results for the fourth quarter and fiscal year ended December 31, 2015. Financial Highlights. ConfirmMDx revenue up 62% to $15.2 million in 2015 compared to $9.4 million in 2014. Total full-year 2015 revenue up 51%
MDxHealth communique ses résultats financiers T2 et S1 2023
WebMDxHealth communique ses résultats financiers T2 et S1 2023. COMMUNIQUÉ DE PRESSE – INFORMATIONS RÉGLEMENTÉES23 AOÛT 2023, 16 h 00 EDT, 22 h 00 CET. MDxHealth communique ses résultats financiers T2 et S1 2023. Les revenus du T2 ont augmenté de 143 % par rapport à l’année dernière pour atteindre 16,7 …
MDxHealth Announces Launch of Offering of ADSs in the United …
WebNEWS RELEASE – REGULATED INFORMATION INSIDE INFORMATION FEBRUARY 1, 2023, 4PM ET/ 22:00 CET. IRVINE, CA, and HERSTAL, BELGIUM –February 1, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH) (“mdxhealth” or the “Company“), a commercial-stage precision diagnostics company, announced the launch of a proposed offering of …
MDxHealth Reports Financial Year 2019 Results and Provides …
WebConference call with Q&A today at 09:00 CET / 08:00 GMT, details provided below. IRVINE, CA, and HERSTAL, BELGIUM – February 26, 2020 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today announced its financial results for the year ended December 31, 2019 and …
MDxHealth Provides Q3-2020 Business Update
WebNEWS RELEASE – REGULATED INFORMATION 21 OCTOBER 2020, 07:00 A.M. CEST IRVINE, CA, and HERSTAL, BELGIUM – October 21, 2020 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today provided a business update for the third quarter ended September 30, 2020, and …
MDxHealth Provides Updated and Supplemental Financial …
WebNEWS RELEASE –REGULATED INFORMATION 20 JANUARY 2023, 1:00 am ET / 7:00 am CET. IRVINE, CA, and HERSTAL, BELGIUM – January 20, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today provided supplemental information related to its acquisition of the …
MDxHealth Launches AssureMDx for Bladder Cancer Liquid Biopsy …
WebIRVINE, CA, and HERSTAL, BELGIUM – 07:00 CEST, July 6, 2017 – MDxHealth SA (Euronext: MDXH.BR) today announced the commercial launch of its AssureMDx (TM) for Bladder Cancer test in the United States as a laboratory developed test (LDT). Testing will be conducted at the Company’s state-of-the-art CAP and CLIA accredited laboratory
MDxHealth Reports Half Year 2021 Results
WebNEWS RELEASE – REGULATED INFORMATION 26 AUGUST 2021, 18:00 CET. MDxHealth Reports Half Year 2021 Results . Conference call with Q&A today at 19:00 CET / 1PM US ET, details provided below. IRVINE, CA, and HERSTAL, BELGIUM – August 26, 2021 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage precision diagnostics …
MDxHealth annonce la réalisation de sa transition vers une …
WebCOMMUNIQUÉ DE PRESSE – INFORMATION RÉGLEMENTÉE. 18 DECEMBRE 2023, 01:00 ET / 07:00 CET. IRVINE, CA, et HERSTAL, BELGIQUE – 18 decembre 2023 – MDxHealth SA (NASDAQ/Euronext Brussels : MDXH) (la ” Société ” ou ” mdxhealth “), une société spécialisée dans le diagnostic de précision à un stade commercial, annonce …
MDxHealth to Participate in 43
WebNEWS RELEASEFEBRUARY 28, 2023, 4:30 pm ET/ 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 28, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH), a commercial-stage precision diagnostics company, today announced that Michael McGarrity, chief executive officer, will present at Cowen’s 43rd Annual …
MDxHealth Epigenetic Biomarkers Identify Men at Increased Risk …
WebMost recently the Chief Commercial Officer of Sterilis Solutions Prior to Sterilis Solutions he served as the commercial leader for Pharmacogenomic companies Assurex Health and AltheaDx. While at Assurex Health (Myriad Genetics) revenue grew from $700k to a run rate of $100 Million during his 5 year span with the organization.
MDxHealth Reports Highmark Blue Cross Blue Shield Issues …
WebHighmark is a national, diversified health care partner based in Pittsburgh that serves members across the United States through businesses in health insurance, dental insurance, vision care and reinsurance. Highmark, and its affiliates, operate health insurance plans in Pennsylvania, Delaware and West Virginia that serve 5.2 million …
MDxHealth Successfully Completes a EUR 25.0 Million (USD 30.4 …
WebNEWS RELEASE – REGULATED INFORMATION – INSIDE INFORMATION 21 January 2021, 11:30 p.m. CET IRVINE, CA, and HERSTAL, BELGIUM – 21 January 2021 – MDxHealth SA (Euronext Brussels: MDXH) (the “Company” or “MDxHealth“), a commercial-stage innovative molecular diagnostics company, announces the successful …
MDxHealth Reports Financial Year 2020 Results and Provides …
WebNEWS RELEASE – REGULATED INFORMATION 3 MARCH 2021, 07:00 A.M. CET Conference call with Q&A today at 08:00 CET / 07:00 GMT, details provided below. IRVINE, CA, and HERSTAL, BELGIUM – March 3, 2021 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today announced its …
MDxHealth Provides Q1-2021 Business Update
WebNEWS RELEASE – REGULATED INFORMATION 21 APRIL 2021, 07:00 A.M. CET. IRVINE, CA, and HERSTAL, BELGIUM – April 21, 2021 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today provided a business update for the first quarter ended March 31, 2021.. Michael …
MDxHealth Announces Pricing of Offering of ADSs in the United …
WebNEWS RELEASE – REGULATED INFORMATION INSIDE INFORMATION FEBRUARY 3, 2023, 8:00 am ET/ 14:00 CET. IRVINE, CA, and HERSTAL, BELGIUM – February 3, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH) (“mdxhealth” or the “Company“), a commercial-stage precision diagnostics company, today announced that it …
MDxHealth Acquires NovioGendix to Expand Uro-Oncology …
WebUrine based test shown to be clinically superior to PCA3 prostate cancer test. $8.8 million total acquisition cost, including $5.1 million in MDxHealth stock, $280,000 in cash, and up to an additional $3.3 million in cash in future milestones. Prof. Dr. Jack A. Schalken, Co-Founder of NovioGendix, proposed to join MDxHealth as an Independent
Top Categories
Popular Searched
› Wellspace health inc doctors
› Social selection theory health inequalities
› Wellspace health sacramento ca
› Healthcare social networks review
› Health care professionals social networks
› Social inequality social network and health
› Geha united healthcare medicare advantage
› Wellspace health email address
Recently Searched
› Whole health coach & massage
› Health career institute in laredo
› Health summit 2023 baton rouge
› Cylex rochester healthy living centre
› City college of health application form
› Africa mental health foundation kenya
› Health authority of anguilla
› Principles of district health system
› Cdc school health profiles 2020